Departments and specialties
Mayo Clinic has one of the largest and most experienced practices in the United States,
with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work
together to ensure quality care and successful recovery.
Departments that treat this condition
Doctors who treat this condition
Displaying 1-1 out of 1 doctors available
- Rochester, MN
Areas of focus:
Macroglobulinemia, Multiple myeloma, Amyloidosis, Monoclonal gammopathy of undetermined significance
Researchers at Mayo Clinic coined the term "monoclonal gammopathy of undetermined significance" (MGUS) and have been studying the disorder for decades.
Specific efforts involve determining risk factors for developing the condition, how these risk factors might influence treatment, and how to prevent progression of MGUS to blood cancers and other conditions.
Doctors and scientists in the Hematologic Malignancies Program of the Mayo Clinic Cancer Center are working on improving the diagnosis and treatment of myeloma and other blood disorders.
See a list of publications on monoclonal gammopathy of undetermined significance (MGUS) by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.
Monoclonal gammopathy of undetermined significance (MGUS) care at Mayo Clinic
July 22, 2021
Products & Services
Monoclonal gammopathy of undetermined significance (MGUS)